SPL 0.00% 9.5¢ starpharma holdings limited

Ann: AstraZeneca presents 1st DEP candidate as Bcl2/xL inhibitor, page-78

  1. 3,407 Posts.
    lightbulb Created with Sketch. 810
    Yes I know all that. And I'll say again that most broker and analyst reports, recommendations including valuations are more akin to kindergarten fingerprinting than a masterpiece. Most aren't worth the paper they are written on. Best bet is for people to do their own research.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.000(0.00%)
Mkt cap ! $39.64M
Open High Low Value Volume
9.7¢ 9.7¢ 9.5¢ $19.64K 204.3K

Buyers (Bids)

No. Vol. Price($)
2 69731 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 5390 1
View Market Depth
Last trade - 16.10pm 09/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.